Genesco Inc. Reports Fiscal 2025 Third Quarter Results
Genesco (NYSE: GCO) reported Q3 FY2025 results with total net sales increasing 3% to $596 million and comparable sales rising 6%. Journeys, the company's key segment, showed strong performance with an 11% comparable sales increase. E-commerce sales grew significantly, representing 24% of retail sales with a 15% increase in comparable sales.
The company raised its fiscal 2025 guidance, now expecting total sales to be down 1% to flat compared to FY2024, or flat to up 1% excluding the 53rd week. Adjusted EPS guidance was raised to $0.80-$1.00. The quarter's GAAP loss was ($1.76) per share, while adjusted EPS was $0.61.
Genesco (NYSE: GCO) ha riportato i risultati del terzo trimestre dell'anno fiscale 2025, con un aumento delle vendite nette totali del 3%, pari a 596 milioni di dollari, e un incremento del 6% delle vendite comparabili. Journeys, il segmento principale dell'azienda, ha mostrato una performance forte con un aumento delle vendite comparabili dell'11%. Le vendite e-commerce sono cresciute in modo significativo, rappresentando il 24% delle vendite al dettaglio con un aumento del 15% delle vendite comparabili.
L'azienda ha rivisto al rialzo le previsioni per l'anno fiscale 2025, ora prevedendo una diminuzione delle vendite totali dell'1% o una sostanziale stabilità rispetto all'anno fiscale 2024, oppure una stabilità fino a un aumento dell'1%, escludendo la 53ª settimana. La guida per l'EPS rettificato è stata alzata a $0,80-$1,00. La perdita GAAP per il trimestre è stata di ($1,76) per azione, mentre l'EPS rettificato è stato di $0,61.
Genesco (NYSE: GCO) reportó los resultados del tercer trimestre del año fiscal 2025, con un aumento del 3% en las ventas netas totales, alcanzando los 596 millones de dólares, y un incremento del 6% en las ventas comparables. Journeys, el segmento clave de la empresa, mostró un rendimiento sólido con un aumento del 11% en las ventas comparables. Las ventas de comercio electrónico crecieron significativamente, representando el 24% de las ventas minoristas con un aumento del 15% en las ventas comparables.
La empresa ha elevado su pronóstico para el año fiscal 2025, ahora esperando que las ventas totales disminuyan un 1% o permanezcan estables en comparación con el año fiscal 2024, o que permanezcan estables hasta un aumento del 1%, excluyendo la 53ª semana. La guía para el EPS ajustado se elevó a $0.80-$1.00. La pérdida GAAP para el trimestre fue de ($1.76) por acción, mientras que el EPS ajustado fue de $0.61.
Genesco (NYSE: GCO)는 2025 회계연도 3분기 실적을 발표하며 총 순매출이 3% 증가하여 5억 9600만 달러, 비교 가능한 매출은 6% 증가했다고 보고했습니다. Journeys는 회사의 주요 부문으로, 비교 가능한 매출이 11% 증가하며 강력한 실적을 보였습니다. 전자상거래 판매는 크게 성장하여 소매 판매의 24%를 차지하며 비교 가능한 매출이 15% 증가했습니다.
회사는 2025 회계연도 전망을 상향 조정했으며, 현재 총 매출이 2024 회계연도에 비해 1% 감소하거나 보합세일 것으로 예상하고 있으며, 53주 차를 제외하면 보합세에서 1% 증가할 것으로 보입니다. 조정된 EPS 가이던스도 $0.80-$1.00로 상향 조정되었습니다. 이번 분기의 GAAP 손실은 주당 ($1.76)로, 조정된 EPS는 $0.61이었습니다.
Genesco (NYSE: GCO) a annoncé les résultats du troisième trimestre de l'exercice 2025, avec des ventes nettes totales en hausse de 3%, atteignant 596 millions de dollars, et des ventes comparables en hausse de 6%. Journeys, le segment clé de l'entreprise, a affiché une performance solide avec une augmentation des ventes comparables de 11%. Les ventes en ligne ont connu une forte croissance, représentant 24% des ventes au détail, avec une augmentation des ventes comparables de 15%.
L'entreprise a révisé à la hausse ses prévisions pour l'exercice 2025, s'attendant désormais à ce que les ventes totales diminuent de 1% ou restent stables par rapport à l'exercice 2024, ou restent stables avec une augmentation allant jusqu'à 1%, sans compter la 53e semaine. Les prévisions pour le BPA ajusté ont été relevées à 0,80 à 1,00 $. La perte GAAP pour le trimestre était de ($1,76) par action, tandis que le BPA ajusté était de 0,61 $.
Genesco (NYSE: GCO) hat die Ergebnisse für das dritte Quartal des Geschäftsjahres 2025 bekannt gegeben, wobei der Gesamtumsatz um 3% auf 596 Millionen Dollar gestiegen ist und die vergleichbaren Verkäufe um 6% zugenommen haben. Journeys, das Hauptsegment des Unternehmens, zeigte eine starke Leistung mit einem Anstieg der vergleichbaren Verkäufe um 11%. Der E-Commerce-Umsatz wuchs signifikant und machte 24% des Einzelhandelsumsatzes aus, mit einem Anstieg der vergleichbaren Verkäufe um 15%.
Das Unternehmen hat seine Prognose für das Geschäftsjahr 2025 angehoben und erwartet nun, dass der Gesamtumsatz um 1% zurückgeht oder stabil bleibt im Vergleich zum Geschäftsjahr 2024, oder stabil bleibt bis zu einem Anstieg von 1%, ohne die 53. Woche zu berücksichtigen. Die Prognose für den anpassbaren EPS wurde auf $0,80-$1,00 angehoben. Der GAAP-Verlust für das Quartal betrug ($1,76) pro Aktie, während der anpassbare EPS bei $0,61 lag.
- Total net sales increased 3% to $596 million
- Comparable sales increased 6% with e-commerce sales up 15%
- Journeys segment showed strong 11% comparable sales growth
- E-commerce sales increased to 24% of retail sales from 21%
- Raised full-year sales and EPS guidance
- GAAP loss of $1.76 per share in Q3
- Gross margin decreased 30 basis points to 47.8%
- Schuh and Johnston & Murphy segments showed declining comparable sales (-1%)
- Total debt of $100.1 million at quarter end
- Store count decreased 4% year-over-year
Insights
Genesco's Q3 FY25 results demonstrate meaningful improvement, with total net sales increasing 3% to
The company's improved outlook, raising FY25 adjusted EPS guidance to
The balance sheet shows progress with reduced debt levels and controlled inventory growth of just
The results reveal a compelling turnaround story at Journeys, driven by strategic improvements in product assortment and store presentation. The strong performance during back-to-school season and sustained momentum through Black Friday indicates successful execution of their consumer experience enhancement strategy.
The
The company's cautious outlook for Schuh and Johnston & Murphy reflects realistic assessment of current market conditions, while maintaining focus on long-term strategic initiatives to drive profitable growth.
--Results Exceed Expectations, Driven by Journeys--
--Total Comparable Sales Increased
--Raises Fiscal 2025 Guidance—
Third Quarter Fiscal 2025 Financial Summary
-
Total net sales increased
3% to ; comparable sales increased$596 million 6% -
Comparable e-commerce sales increased
15% ; comparable store sales increased4% -
E-commerce sales represented
24% of retail sales compared to21% last year -
GAAP EPS was (
) and Non-GAAP EPS was$1.76 1$0.61 -
Raises sales guidance to down
1% to flat compared to Fiscal 2024, or flat to up1% excluding the 53rd week in Fiscal 2024 -
Raises Fiscal 2025 adjusted EPS guidance to
to$0.80 2$1.00
Mimi E. Vaughn, Genesco’s Board Chair, President and Chief Executive Officer, said, “Our quarterly performance once again exceeded expectations and marked a return to positive overall comparable sales. Following a strong start to the third quarter including the heart of back-to-school, sales trends at Journeys remained robust in September and October, fueling a double-digit comp gain for the business. This result was driven by the initial phase of Journeys’ strategic growth plan which has focused on elevating the consumer experience including improving the product assortment and visually resetting our stores. EPS would have been stronger without the shift of an important back-to-school week into the second quarter this year.”
__________________________ |
1Excludes charges for asset impairments, net of tax effect in the third quarter of Fiscal 2025 (“Excluded Items”). Also excludes income tax expense of |
2A reconciliation of the adjusted financial measures cited in the guidance to their corresponding measures as reported pursuant to GAAP is included in Schedule B to this press release. |
Vaughn continued, “We are pleased with Journeys’ start to the fourth quarter including the important Black Friday/Cyber Monday period, especially as demand for several discretionary categories including footwear continues to be very selective and event driven. Based on the current variability of consumer demand and shopping trends, we have adopted a more cautious view for Schuh and Johnston & Murphy over the remainder of this year.
“We are in the very early innings of returning Journeys and the overall company to historical rates of sales and profitability. With the progress we’ve recently made, and our track record of successfully evolving our businesses in response to changing consumer preferences and purchasing behavior, I feel confident we have the experience and strategies to drive profitable growth across the Company and create greater value for our shareholders over the near- and long-term.”
Third Quarter Review
Net sales for the third quarter of Fiscal 2025 of
Comparable Sales |
||||
|
|
|
||
Comparable Same Store and E-commerce Sales: |
3QFY25 |
3QFY24 |
||
Journeys Group |
|
(8)% |
||
Schuh Group |
(1)% |
|
||
Johnston & Murphy Group |
(1)% |
|
||
Total Genesco Comparable Sales |
|
(4)% |
||
Same Store Sales |
|
(7)% |
||
Comparable E-commerce Sales |
|
|
The overall sales increase for the third quarter of Fiscal 2025 compared to the third quarter of Fiscal 2024 was driven by an increase of
Third quarter gross margin this year decreased 30 basis points as a percentage of sales to
Selling and administrative expense for the third quarter this year decreased 10 basis points as a percentage of sales to
Genesco’s GAAP operating income for the third quarter was
The effective tax rate for the quarter was
The GAAP loss from continuing operations was
Cash, Borrowings and Inventory
Cash as of November 2, 2024, was
Capital Expenditures and Store Activity
For the third quarter this year, capital expenditures were
Share Repurchases
The Company repurchased 17,922 shares during the third quarter of Fiscal 2025 for
Store Closing and Cost Savings Update
- The Company closed 12 Journeys stores in the third quarter of Fiscal 2025 (for a total of 41 Journeys stores closed to date in Fiscal 2025) and expects to close up to another 10 Journeys stores in Fiscal 2025
-
The Company's cost savings program remains on track to achieve a reduction in the annualized run rate of
to$45 by the end of Fiscal 2025$50 million
Fiscal 2025 Outlook
For Fiscal 2025, the Company:
-
Now expects total sales to be down
1% to flat compared to Fiscal 2024, or flat to up1% excluding the 53rd week in Fiscal 2024 versus prior expectations for a total sales decrease of1% to2% , or flat to down1% excluding the 53rd week in Fiscal 2024 -
Now expects adjusted diluted earnings per share from continuing operations in the range of
to$0.80 versus prior guidance of$1.00 to$0.60 2$1.00 -
Guidance assumes no further share repurchases and a tax rate of
27%
Conference Call, Management Commentary and Investor Presentation
The Company has posted detailed financial commentary and a supplemental financial presentation of third quarter results on its website, www.genesco.com, in the investor relations section. The Company's live conference call on December 6, 2024, at 7:30 a.m. (Central time), may be accessed through the Company's website, www.genesco.com. To listen live, please go to the website at least 15 minutes early to register, download and install any necessary software.
__________________________ |
2A reconciliation of the adjusted financial measures cited in the guidance to their corresponding measures as reported pursuant to GAAP is included in Schedule B to this press release. |
Safe Harbor Statement
This release contains forward-looking statements, including those regarding future sales, earnings, operating income, gross margins, expenses, capital expenditures, depreciation and amortization, tax rates, store openings and closures, cost reductions, ESG progress and all other statements not addressing solely historical facts or present conditions. Forward-looking statements are usually identified by or are associated with such words as “intend,” “expect,” “feel,” “should,” “believe,” “anticipate,” “optimistic,” “confident” and similar terminology. Actual results could vary materially from the expectations reflected in these statements. A number of factors could cause differences. These include adjustments to projections reflected in forward-looking statements, including those resulting from weakness in store and shopping mall traffic, restrictions on operations imposed by government entities and/or landlords, changes in public safety and health requirements, and limitations on the Company’s ability to adequately staff and operate stores. Differences from expectations could also result from store closures and effects on the business as a result of the level and timing of promotional activity necessary to maintain inventories at appropriate levels; our ability to pass on price increases to our customers; the imposition of tariffs on product imported by the Company or its vendors as well as the ability and costs to move production of products in response to tariffs; the Company’s ability to obtain from suppliers products that are in-demand on a timely basis and effectively manage disruptions in product supply or distribution, including disruptions as a result of pandemics or geopolitical events, including shipping disruptions in the Red Sea; unfavorable trends in fuel costs, foreign exchange rates, foreign labor and material costs, and other factors affecting the cost of products; civil disturbances; our ability to renew our license agreements; impacts of the
About Genesco Inc.
Genesco Inc. (NYSE: GCO) is a footwear focused company with distinctively positioned retail and lifestyle brands and proven omnichannel capabilities offering customers the footwear they desire in engaging shopping environments, including 1,302 retail stores and branded e-commerce websites. Its Journeys, Little Burgundy and Schuh brands serve teens, kids and young adults with on-trend fashion footwear inspired by youth culture in the
GENESCO INC. | ||||||||||||||
Condensed Consolidated Statements of Operations | ||||||||||||||
(in thousands, except per share data) | ||||||||||||||
(Unaudited) | ||||||||||||||
Quarter 3 | Quarter 3 | |||||||||||||
Nov. 2, |
|
% of |
|
Oct. 28, |
|
% of |
||||||||
2024 |
|
Net Sales |
|
2023 |
|
Net Sales |
||||||||
Net sales | $ |
596,328 |
|
100.0 |
% |
$ |
579,315 |
|
100.0 |
% |
||||
Cost of sales |
|
311,072 |
|
52.2 |
% |
|
300,890 |
|
51.9 |
% |
||||
Gross margin |
|
285,256 |
|
47.8 |
% |
|
278,425 |
|
48.1 |
% |
||||
Selling and administrative expenses |
|
274,912 |
|
46.1 |
% |
|
267,474 |
|
46.2 |
% |
||||
Asset impairments and other, net(1) |
|
134 |
|
0.0 |
% |
|
99 |
|
0.0 |
% |
||||
Operating income |
|
10,210 |
|
1.7 |
% |
|
10,852 |
|
1.9 |
% |
||||
Other components of net periodic benefit cost |
|
86 |
|
0.0 |
% |
|
148 |
|
0.0 |
% |
||||
Interest expense, net |
|
1,213 |
|
0.2 |
% |
|
2,207 |
|
0.4 |
% |
||||
Earnings from continuing operations before income taxes |
|
8,911 |
|
1.5 |
% |
|
8,497 |
|
1.5 |
% |
||||
Income tax expense(2) |
|
27,759 |
|
4.7 |
% |
|
1,908 |
|
0.3 |
% |
||||
Earnings (loss) from continuing operations |
|
(18,848 |
) |
-3.2 |
% |
|
6,589 |
|
1.1 |
% |
||||
Loss from discontinued operations, net of tax |
|
(84 |
) |
0.0 |
% |
|
(50 |
) |
0.0 |
% |
||||
Net Earnings (Loss) | $ |
(18,932 |
) |
-3.2 |
% |
$ |
6,539 |
|
1.1 |
% |
||||
Basic earnings (loss) per share: | ||||||||||||||
Before discontinued operations | $ |
(1.76 |
) |
$ |
0.60 |
|
||||||||
Net earnings (loss) | $ |
(1.76 |
) |
$ |
0.60 |
|
||||||||
Diluted earnings (loss) per share: | ||||||||||||||
Before discontinued operations | $ |
(1.76 |
) |
$ |
0.60 |
|
||||||||
Net earnings (loss) | $ |
(1.76 |
) |
$ |
0.60 |
|
||||||||
Weighted-average shares outstanding: | ||||||||||||||
Basic |
|
10,737 |
|
|
10,898 |
|
||||||||
Diluted |
|
10,737 |
|
|
10,972 |
|
||||||||
(1) Includes a |
||||||||||||||
(2) Includes a |
Condensed Consolidated Statements of Operations | ||||||||||||||
(in thousands, except per share data) | ||||||||||||||
(Unaudited) | ||||||||||||||
Nine Months Ended | Nine Months Ended | |||||||||||||
Nov. 2, |
|
% of |
|
Oct. 28, |
|
% of |
||||||||
2024 |
|
Net Sales |
|
2023 |
|
Net Sales |
||||||||
Net sales | $ |
1,579,113 |
|
100.0 |
% |
$ |
1,585,674 |
|
100.0 |
% |
||||
Cost of sales |
|
831,937 |
|
52.7 |
% |
|
828,921 |
|
52.3 |
% |
||||
Gross margin(1) |
|
747,176 |
|
47.3 |
% |
|
756,753 |
|
47.7 |
% |
||||
Selling and administrative expenses |
|
777,878 |
|
49.3 |
% |
|
778,491 |
|
49.1 |
% |
||||
Goodwill impairment |
|
- |
|
0.0 |
% |
|
28,453 |
|
1.8 |
% |
||||
Asset impairments and other, net(2) |
|
1,490 |
|
0.1 |
% |
|
581 |
|
0.0 |
% |
||||
Operating loss |
|
(32,192 |
) |
-2.0 |
% |
|
(50,772 |
) |
-3.2 |
% |
||||
Other components of net periodic benefit cost |
|
281 |
|
0.0 |
% |
|
388 |
|
0.0 |
% |
||||
Interest expense, net |
|
3,448 |
|
0.2 |
% |
|
6,241 |
|
0.4 |
% |
||||
Loss from continuing operations before income taxes |
|
(35,921 |
) |
-2.3 |
% |
|
(57,401 |
) |
-3.6 |
% |
||||
Income tax expense (benefit)(3) |
|
17,144 |
|
1.1 |
% |
|
(13,483 |
) |
-0.9 |
% |
||||
Loss from continuing operations |
|
(53,065 |
) |
-3.4 |
% |
|
(43,918 |
) |
-2.8 |
% |
||||
Loss from discontinued operations, net of tax |
|
(206 |
) |
0.0 |
% |
|
(98 |
) |
0.0 |
% |
||||
Net Loss | $ |
(53,271 |
) |
-3.4 |
% |
$ |
(44,016 |
) |
-2.8 |
% |
||||
Basic loss per share: | ||||||||||||||
Before discontinued operations | $ |
(4.88 |
) |
$ |
(3.87 |
) |
||||||||
Net loss | $ |
(4.90 |
) |
$ |
(3.88 |
) |
||||||||
Diluted loss per share: | ||||||||||||||
Before discontinued operations | $ |
(4.88 |
) |
$ |
(3.87 |
) |
||||||||
Net loss | $ |
(4.90 |
) |
$ |
(3.88 |
) |
||||||||
Weighted-average shares outstanding: | ||||||||||||||
Basic |
|
10,870 |
|
|
11,353 |
|
||||||||
Diluted |
|
10,870 |
|
|
11,353 |
|
||||||||
(1) Includes a |
||||||||||||||
(2) Includes a |
||||||||||||||
(3) Includes a |
Sales/Earnings Summary by Segment | ||||||||||||||
(in thousands) | ||||||||||||||
(Unaudited) | ||||||||||||||
Quarter 3 | Quarter 3 | |||||||||||||
Nov. 2, |
|
% of |
|
Oct. 28, |
|
% of |
||||||||
2024 |
|
Net Sales |
|
2023 |
|
Net Sales |
||||||||
Sales: | ||||||||||||||
Journeys Group | $ |
362,517 |
|
60.8 |
% |
$ |
349,367 |
|
60.3 |
% |
||||
Schuh Group |
|
121,826 |
|
20.4 |
% |
|
118,129 |
|
20.4 |
% |
||||
Johnston & Murphy Group |
|
78,463 |
|
13.2 |
% |
|
81,411 |
|
14.1 |
% |
||||
Genesco Brands Group |
|
33,522 |
|
5.6 |
% |
|
30,408 |
|
5.2 |
% |
||||
Net Sales | $ |
596,328 |
|
100.0 |
% |
$ |
579,315 |
|
100.0 |
% |
||||
Operating Income (Loss): | ||||||||||||||
Journeys Group | $ |
13,166 |
|
3.6 |
% |
$ |
11,975 |
|
3.4 |
% |
||||
Schuh Group |
|
3,119 |
|
2.6 |
% |
|
5,484 |
|
4.6 |
% |
||||
Johnston & Murphy Group |
|
(91 |
) |
-0.1 |
% |
|
2,706 |
|
3.3 |
% |
||||
Genesco Brands Group |
|
3,729 |
|
11.1 |
% |
|
(1,560 |
) |
-5.1 |
% |
||||
Corporate and Other(1) |
|
(9,713 |
) |
-1.6 |
% |
|
(7,753 |
) |
-1.3 |
% |
||||
Operating income |
|
10,210 |
|
1.7 |
% |
|
10,852 |
|
1.9 |
% |
||||
Other components of net periodic benefit cost |
|
86 |
|
0.0 |
% |
|
148 |
|
0.0 |
% |
||||
Interest, net |
|
1,213 |
|
0.2 |
% |
|
2,207 |
|
0.4 |
% |
||||
Earnings from continuing operations before income taxes |
|
8,911 |
|
1.5 |
% |
|
8,497 |
|
1.5 |
% |
||||
Income tax expense(2) |
|
27,759 |
|
4.7 |
% |
|
1,908 |
|
0.3 |
% |
||||
Earnings (loss) from continuing operations |
|
(18,848 |
) |
-3.2 |
% |
|
6,589 |
|
1.1 |
% |
||||
Loss from discontinued operations, net of tax |
|
(84 |
) |
0.0 |
% |
|
(50 |
) |
0.0 |
% |
||||
Net Earnings (Loss) | $ |
(18,932 |
) |
-3.2 |
% |
$ |
6,539 |
|
1.1 |
% |
||||
(1) Includes a |
||||||||||||||
(2) Includes a |
GENESCO INC. | ||||||||||||||
Sales/Earnings Summary by Segment | ||||||||||||||
(in thousands) | ||||||||||||||
(Unaudited) | ||||||||||||||
Nine Months Ended | Nine Months Ended | |||||||||||||
Nov. 2, |
|
% of |
|
Oct. 28, |
|
% of |
||||||||
2024 |
|
Net Sales |
|
2023 |
|
Net Sales |
||||||||
Sales: | ||||||||||||||
Journeys Group | $ |
920,808 |
|
58.3 |
% |
$ |
908,832 |
|
57.3 |
% |
||||
Schuh Group |
|
338,736 |
|
21.5 |
% |
|
334,033 |
|
21.1 |
% |
||||
Johnston & Murphy Group |
|
228,707 |
|
14.5 |
% |
|
241,823 |
|
15.3 |
% |
||||
Genesco Brands Group |
|
90,862 |
|
5.8 |
% |
|
100,986 |
|
6.4 |
% |
||||
Net Sales | $ |
1,579,113 |
|
100.0 |
% |
$ |
1,585,674 |
|
100.0 |
% |
||||
Operating Income (Loss): | ||||||||||||||
Journeys Group | $ |
(16,807 |
) |
-1.8 |
% |
$ |
(21,265 |
) |
-2.3 |
% |
||||
Schuh Group |
|
4,562 |
|
1.3 |
% |
|
12,110 |
|
3.6 |
% |
||||
Johnston & Murphy Group |
|
1,861 |
|
0.8 |
% |
|
10,178 |
|
4.2 |
% |
||||
Genesco Brands Group(1) |
|
5,415 |
|
6.0 |
% |
|
259 |
|
0.3 |
% |
||||
Corporate and Other(2) |
|
(27,223 |
) |
-1.7 |
% |
|
(23,601 |
) |
-1.5 |
% |
||||
Goodwill Impairment |
|
- |
|
0.0 |
% |
|
(28,453 |
) |
-1.8 |
% |
||||
Operating loss |
|
(32,192 |
) |
-2.0 |
% |
|
(50,772 |
) |
-3.2 |
% |
||||
Other components of net periodic benefit cost |
|
281 |
|
0.0 |
% |
|
388 |
|
0.0 |
% |
||||
Interest, net |
|
3,448 |
|
0.2 |
% |
|
6,241 |
|
0.4 |
% |
||||
Loss from continuing operations before income taxes |
|
(35,921 |
) |
-2.3 |
% |
|
(57,401 |
) |
-3.6 |
% |
||||
Income tax expense (benefit)(3) |
|
17,144 |
|
1.1 |
% |
|
(13,483 |
) |
-0.9 |
% |
||||
Loss from continuing operations |
|
(53,065 |
) |
-3.4 |
% |
|
(43,918 |
) |
-2.8 |
% |
||||
Loss from discontinued operations, net of tax |
|
(206 |
) |
0.0 |
% |
|
(98 |
) |
0.0 |
% |
||||
Net Loss | $ |
(53,271 |
) |
-3.4 |
% |
$ |
(44,016 |
) |
-2.8 |
% |
||||
(1) Includes a |
||||||||||||||
(2) Includes a |
||||||||||||||
(3) Includes a |
GENESCO INC. | ||||||
Condensed Consolidated Balance Sheets | ||||||
(in thousands) | ||||||
(Unaudited) | ||||||
November 2, 2024 |
October 28, 2023 |
|||||
Assets | ||||||
Cash | $ |
33,578 |
$ |
21,691 |
||
Accounts receivable |
|
52,373 |
|
56,934 |
||
Inventories |
|
523,152 |
|
516,735 |
||
Other current assets |
|
50,600 |
|
43,350 |
||
Total current assets |
|
659,703 |
|
638,710 |
||
Property and equipment |
|
230,090 |
|
245,009 |
||
Operating lease right of use assets |
|
424,886 |
|
459,524 |
||
Goodwill and other intangibles |
|
36,444 |
|
35,725 |
||
Non-current prepaid income taxes |
|
58,670 |
|
55,632 |
||
Other non-current assets |
|
25,728 |
|
58,331 |
||
Total Assets | $ |
1,435,521 |
$ |
1,492,931 |
||
Liabilities and Equity | ||||||
Accounts payable | $ |
214,935 |
$ |
186,683 |
||
Current portion operating lease liabilities |
|
123,397 |
|
134,850 |
||
Other current liabilities |
|
83,750 |
|
75,631 |
||
Total current liabilities |
|
422,082 |
|
397,164 |
||
Long-term debt |
|
100,114 |
|
128,163 |
||
Long-term operating lease liabilities |
|
348,672 |
|
387,347 |
||
Other long-term liabilities |
|
47,749 |
|
43,299 |
||
Equity |
|
516,904 |
|
536,958 |
||
Total Liabilities and Equity | $ |
1,435,521 |
$ |
1,492,931 |
GENESCO INC. | ||||||||||||||
Store Count Activity | ||||||||||||||
Balance |
|
|
|
|
|
Balance |
|
|
|
|
|
Balance |
||
01/28/23 |
|
Open |
|
Close |
|
02/03/24 |
|
Open |
|
Close |
|
11/02/24 |
||
Journeys Group | 1,130 |
27 |
94 |
1,063 |
6 |
41 |
1,028 |
|||||||
Schuh Group | 122 |
3 |
3 |
122 |
2 |
2 |
122 |
|||||||
Johnston & Murphy Group | 158 |
2 |
4 |
156 |
0 |
4 |
152 |
|||||||
Total Retail Stores | 1,410 |
32 |
101 |
1,341 |
8 |
47 |
1,302 |
GENESCO INC. | ||||||||
Store Count Activity | ||||||||
Balance |
|
|
|
|
|
Balance |
||
08/03/24 |
|
Open |
|
Close |
|
11/02/24 |
||
Journeys Group | 1,039 |
1 |
12 |
1,028 |
||||
Schuh Group | 123 |
1 |
2 |
122 |
||||
Johnston & Murphy Group | 152 |
0 |
0 |
152 |
||||
Total Retail Stores | 1,314 |
2 |
14 |
1,302 |
GENESCO INC. | |||||||||||||
Comparable Sales | |||||||||||||
Quarter 3 | Nine Months | ||||||||||||
Nov. 2, |
Oct. 28, |
Nov. 2, |
Oct. 28, |
||||||||||
2024 |
2023 |
2024 |
2023 |
||||||||||
Journeys Group | 11 |
% |
-8 |
% |
2 |
% |
-10 |
% |
|||||
Schuh Group | -1 |
% |
5 |
% |
-3 |
% |
11 |
% |
|||||
Johnston & Murphy Group | -1 |
% |
1 |
% |
-3 |
% |
10 |
% |
|||||
Total Comparable Sales | 6 |
% |
-4 |
% |
0 |
% |
-4 |
% |
|||||
Same Store Sales | 4 |
% |
-7 |
% |
-2 |
% |
-7 |
% |
|||||
Comparable E-commerce Sales | 15 |
% |
8 |
% |
9 |
% |
10 |
% |
Schedule B | ||||||||||||||||||
Genesco Inc. | ||||||||||||||||||
Adjustments to Reported Earnings (Loss) from Continuing Operations | ||||||||||||||||||
Three Months Ended November 2, 2024 and October 28, 2023 | ||||||||||||||||||
The Company believes that disclosure of earnings (loss) and earnings (loss) per share from continuing operations and operating income (loss) adjusted for the items not reflected in the previously announced expectations will be meaningful to investors, especially in light of the impact of such items on the results. | ||||||||||||||||||
Quarter 3 | Quarter 3 | |||||||||||||||||
November 2, 2024 | October 28, 2023 | |||||||||||||||||
Net of | Per Share | Net of | Per Share | |||||||||||||||
In Thousands (except per share amounts) | Pretax | Tax | Amounts | Pretax | Tax | Amounts | ||||||||||||
Earnings (loss) from continuing operations, as reported | $ |
(18,848 |
) |
|
( |
) |
$ |
6,589 |
|
$ |
0.60 |
|
||||||
Gross margin adjustment: | ||||||||||||||||||
Charges related to distribution model transition | $ |
- |
|
6 |
|
|
0.00 |
|
$ |
- |
|
- |
|
|
0.00 |
|
||
Asset impairments and other adjustments: | ||||||||||||||||||
Asset impairment charges | $ |
134 |
|
103 |
|
|
0.01 |
|
$ |
99 |
|
79 |
|
|
0.01 |
|
||
Severance |
|
- |
|
3 |
|
|
0.00 |
|
|
- |
|
- |
|
|
0.00 |
|
||
Impact of additional dilutive shares |
|
- |
|
- |
|
|
0.02 |
|
|
- |
|
- |
|
|
0.00 |
|
||
Total asset impairments and other adjustments | $ |
134 |
|
106 |
|
|
0.03 |
|
$ |
99 |
|
79 |
|
|
0.01 |
|
||
Income tax expense adjustments: | ||||||||||||||||||
Tax impact share based awards |
|
- |
|
|
0.00 |
|
|
48 |
|
|
0.00 |
|
||||||
|
26,250 |
|
|
2.42 |
|
|
- |
|
|
0.00 |
|
|||||||
Other tax items |
|
(920 |
) |
|
(0.08 |
) |
|
(509 |
) |
|
(0.04 |
) |
||||||
Total income tax expense adjustments |
|
25,330 |
|
|
2.34 |
|
|
(461 |
) |
|
(0.04 |
) |
||||||
Adjusted earnings from continuing operations (1) and (2) | $ |
6,594 |
|
|
|
$ |
6,207 |
|
$ |
0.57 |
|
|||||||
(1) The adjusted tax rate for the third quarter of Fiscal 2025 and 2024 is |
||||||||||||||||||
(2) EPS reflects 10.9 million and 11.0 million share count for the third quarter of Fiscal 2025 and 2024, respectively, which includes common stock equivalents in both periods for adjusted earnings from continuing operations. The loss from continuing operations, as reported for the third quarter of Fiscal 2025, excludes common stock equivalents. |
Genesco Inc. | |||||||||||
Adjustments to Reported Operating Income | |||||||||||
Three Months Ended November 2, 2024 and October 28, 2023 | |||||||||||
Quarter 3 - November 2, 2024 | |||||||||||
Operating | Asset Impair | Adj Operating | |||||||||
In Thousands | Income (Loss) | & Other Adj | Income (Loss) | ||||||||
Journeys Group | $ |
13,166 |
|
$ |
- |
$ |
13,166 |
|
|||
Schuh Group |
|
3,119 |
|
|
- |
|
3,119 |
|
|||
Johnston & Murphy Group |
|
(91 |
) |
|
- |
|
(91 |
) |
|||
Genesco Brands Group |
|
3,729 |
|
|
- |
|
3,729 |
|
|||
Corporate and Other |
|
(9,713 |
) |
|
134 |
|
(9,579 |
) |
|||
Total Operating Income | $ |
10,210 |
|
$ |
134 |
$ |
10,344 |
|
|||
% of sales |
|
1.7 |
% |
|
1.7 |
% |
|||||
Quarter 3 - October 28, 2023 | |||||||||||
Operating | Asset Impair | Adj Operating | |||||||||
In Thousands | Income (Loss) | & Other Adj | Income (Loss) | ||||||||
Journeys Group | $ |
11,975 |
|
$ |
- |
$ |
11,975 |
|
|||
Schuh Group |
|
5,484 |
|
|
- |
|
5,484 |
|
|||
Johnston & Murphy Group |
|
2,706 |
|
|
- |
|
2,706 |
|
|||
Genesco Brands Group |
|
(1,560 |
) |
|
- |
|
(1,560 |
) |
|||
Corporate and Other |
|
(7,753 |
) |
|
99 |
|
(7,654 |
) |
|||
Total Operating Income | $ |
10,852 |
|
$ |
99 |
$ |
10,951 |
|
|||
% of sales |
|
1.9 |
% |
|
1.9 |
% |
Schedule B | ||||||||||||||||||
Genesco Inc. | ||||||||||||||||||
Adjustments to Reported Loss from Continuing Operations | ||||||||||||||||||
Nine Months Ended November 2, 2024 and October 28, 2023 | ||||||||||||||||||
The Company believes that disclosure of loss and loss per share from continuing operations and operating loss adjusted for the items not reflected in the previously announced expectations will be meaningful to investors, especially in light of the impact of such items on the results. | ||||||||||||||||||
Nine Months | Nine Months | |||||||||||||||||
November 2, 2024 | October 28, 2023 | |||||||||||||||||
Net of | Per Share | Net of | Per Share | |||||||||||||||
In Thousands (except per share amounts) | Pretax | Tax | Amounts | Pretax | Tax | Amounts | ||||||||||||
Loss from continuing operations, as reported | $ |
(53,065 |
) |
|
( |
) |
$ |
(43,918 |
) |
|
( |
) |
||||||
Gross margin adjustment: | ||||||||||||||||||
Charges related to distribution model transition | $ |
1,750 |
|
1,333 |
|
|
0.12 |
|
$ |
- |
|
- |
|
|
0.00 |
|
||
Asset impairments and other adjustments: | ||||||||||||||||||
Asset impairment charges | $ |
494 |
|
376 |
|
|
0.03 |
|
$ |
581 |
|
446 |
|
|
0.04 |
|
||
Severance |
|
996 |
|
758 |
|
|
0.07 |
|
|
- |
|
- |
|
|
0.00 |
|
||
Goodwill impairment |
|
- |
|
- |
|
|
0.00 |
|
|
28,453 |
|
21,858 |
|
|
1.93 |
|
||
Total asset impairments and other adjustments | $ |
1,490 |
|
1,134 |
|
|
0.10 |
|
$ |
29,034 |
|
22,304 |
|
|
1.97 |
|
||
Income tax expense adjustments: | ||||||||||||||||||
Tax impact share based awards |
|
722 |
|
|
0.07 |
|
|
1,059 |
|
|
0.09 |
|
||||||
|
26,250 |
|
|
2.41 |
|
|
- |
|
|
0.00 |
|
|||||||
Other tax items |
|
(1,842 |
) |
|
(0.17 |
) |
|
(1,578 |
) |
|
(0.14 |
) |
||||||
Total income tax expense adjustments |
|
25,130 |
|
|
2.31 |
|
|
(519 |
) |
|
(0.05 |
) |
||||||
Adjusted loss from continuing operations (1) and (2) | $ |
(25,468 |
) |
|
( |
) |
$ |
(22,133 |
) |
|
( |
) |
||||||
(1) The adjusted tax rate for the first nine months of Fiscal 2025 and 2024 is |
||||||||||||||||||
(2) EPS reflects 10.9 million and 11.4 million share count for the first nine months of Fiscal 2025 and 2024, respectively, which excludes common stock equivalents in the first nine months of each period due to the loss from continuing operations each year. |
Genesco Inc. | ||||||||||||
Adjustments to Reported Operating Income (Loss) and Gross Margin | ||||||||||||
Nine Months Ended November 2, 2024 and October 28, 2023 | ||||||||||||
Nine Months November 2, 2024 | ||||||||||||
Operating | Asset Impair | Adj Operating | ||||||||||
In Thousands | Income (Loss) | & Other Adj | Income (Loss) | |||||||||
Journeys Group | $ |
(16,807 |
) |
$ |
- |
|
$ |
(16,807 |
) |
|||
Schuh Group |
|
4,562 |
|
|
- |
|
|
4,562 |
|
|||
Johnston & Murphy Group |
|
1,861 |
|
|
- |
|
|
1,861 |
|
|||
Genesco Brands Group |
|
5,415 |
|
|
1,750 |
|
|
7,165 |
|
|||
Corporate and Other |
|
(27,223 |
) |
|
1,490 |
|
|
(25,733 |
) |
|||
Total Operating Loss | $ |
(32,192 |
) |
$ |
3,240 |
|
$ |
(28,952 |
) |
|||
% of sales |
|
-2.0 |
% |
|
-1.8 |
% |
||||||
Nine Months October 28, 2023 | ||||||||||||
Operating | Asset Impair | Adj Operating | ||||||||||
In Thousands | Income (Loss) | & Other Adj | Income (Loss) | |||||||||
Journeys Group | $ |
(21,265 |
) |
$ |
- |
|
$ |
(21,265 |
) |
|||
Schuh Group |
|
12,110 |
|
|
- |
|
|
12,110 |
|
|||
Johnston & Murphy Group |
|
10,178 |
|
|
- |
|
|
10,178 |
|
|||
Genesco Brands Group |
|
259 |
|
|
- |
|
|
259 |
|
|||
Goodwill Impairment |
|
(28,453 |
) |
|
28,453 |
|
|
- |
|
|||
Corporate and Other |
|
(23,601 |
) |
|
581 |
|
|
(23,020 |
) |
|||
Total Operating Loss | $ |
(50,772 |
) |
$ |
29,034 |
|
$ |
(21,738 |
) |
|||
% of sales |
|
-3.2 |
% |
|
-1.4 |
% |
||||||
Nine Months | ||||||||||||
In Thousands | Nov. 2, 2024 | Oct. 28, 2023 | ||||||||||
Gross margin, as reported | $ |
747,176 |
|
$ |
756,753 |
|
||||||
% of sales |
|
47.3 |
% |
|
47.7 |
% |
||||||
Charges related to distribution model transition |
|
1,750 |
|
|
- |
|
||||||
Total adjustments |
|
1,750 |
|
|
- |
|
||||||
Adjusted gross margin | $ |
748,926 |
|
$ |
756,753 |
|
||||||
% of sales |
|
47.4 |
% |
|
47.7 |
% |
Schedule B | ||||||||||||
Genesco Inc. | ||||||||||||
Adjustments to Forecasted Earnings from Continuing Operations | ||||||||||||
Fiscal Year Ending February 1, 2025 | ||||||||||||
In millions (except per share amounts) | High Guidance | Low Guidance | ||||||||||
Fiscal 2025 | Fiscal 2025 | |||||||||||
Net of Tax | Per Share | Net of Tax | Per Share | |||||||||
Forecasted earnings from continuing operations | $ |
8.4 |
$ |
0.76 |
$ |
5.8 |
$ |
0.53 |
||||
Charges related to distribution model transition |
|
1.3 |
|
0.12 |
|
1.3 |
|
0.12 |
||||
Asset impairments and other adjustments: | ||||||||||||
Asset impairments and other matters |
|
1.3 |
|
0.12 |
|
1.7 |
|
0.15 |
||||
Total asset impairments and other adjustments (1) |
|
1.3 |
|
0.12 |
|
1.7 |
|
0.15 |
||||
Adjusted forecasted earnings from continuing operations (2) | $ |
11.0 |
$ |
1.00 |
$ |
8.8 |
$ |
0.80 |
||||
(1) All adjustments are net of tax where applicable. The forecasted tax rate for Fiscal 2025 is approximately |
||||||||||||
(2) EPS reflects 11.0 million share count for Fiscal 2025 which includes common stock equivalents. | ||||||||||||
This reconciliation reflects estimates and current expectations of future results. Actual results may vary materially from these expectations and estimates, for reasons including those included in the discussion of forward-looking statements elsewhere in this release. The Company disclaims any obligation to update such expectations and estimates. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20241205691391/en/
Genesco Financial Contacts
Sandra Harris, SVP Finance, Chief Financial Officer
(615) 367-7578 / SHarris2@genesco.com
Tom George, Principal Accounting Officer
(615) 367-7465 / tgeorge@genesco.com
Genesco Media Contact
Claire S. McCall, Director, Corporate Relations
(615) 367-8283 / cmccall@genesco.com
Source: Genesco Inc.
FAQ
What were Genesco's (GCO) Q3 FY2025 sales results?
How did Journeys perform in Genesco's (GCO) Q3 FY2025?
What is Genesco's (GCO) updated FY2025 guidance?